Source:http://linkedlifedata.com/resource/pubmed/id/18806102
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-9-22
|
pubmed:abstractText |
Our aim was to study the effect of 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil on lipid profile, atherogenesis, and liver steatosis in high-fat diet-fed LDL receptor knockout mice. In 4 sets of experiments, mice were distributed into the following groups: control, fed an unfortified diet; Dunaliella 50, fed a diet composed of 50% 9-cis and 50% all-trans beta-carotene; Dunaliella 25, fed a diet containing 25% 9-cis and 75% all-trans beta-carotene; beta-carotene-deficient Dunaliella, fed beta-carotene-deficient Dunaliella powder; and all-trans beta-carotene, fed a synthetic all-trans beta-carotene. All fortified diets contained 0.6% total beta-carotene. Algal 9-cis beta-carotene was absorbed by the mice and accumulated in the liver. Synthetic all-trans beta-carotene was not converted to 9-cis beta-carotene. Dunaliella 50 inhibited high-fat diet-induced plasma cholesterol elevation by 40-63% and reduced cholesterol concentrations in the atherogenic VLDL and LDL. Atherosclerotic lesion area in mice treated with Dunaliella 50 was 60-83% lower compared with mice fed the high-fat diet alone. beta-Carotene-deficient Dunaliella did not influence plasma cholesterol and atherogenesis, suggesting that beta-carotene is essential for a Dunaliella protective effect. Moreover, by administrating Dunaliella powder containing different levels of 9-cis and all-trans beta-carotene isomers, we found that the effect on plasma cholesterol concentration and atherogenesis is 9-cis-dependent. Dunaliella 50 also inhibited fat accumulation and inflammation in the livers of mice fed a high-fat diet, which was accompanied by reduced mRNA levels of inflammatory genes. These results in mice suggest that 9-cis beta-carotene may have the potential to inhibit atherogenesis in humans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1541-6100
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
138
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1923-30
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18806102-Animals,
pubmed-meshheading:18806102-Atherosclerosis,
pubmed-meshheading:18806102-Cholesterol,
pubmed-meshheading:18806102-Diet,
pubmed-meshheading:18806102-Eukaryota,
pubmed-meshheading:18806102-Fatty Liver,
pubmed-meshheading:18806102-Hypercholesterolemia,
pubmed-meshheading:18806102-Intestinal Absorption,
pubmed-meshheading:18806102-Liver,
pubmed-meshheading:18806102-Male,
pubmed-meshheading:18806102-Mice,
pubmed-meshheading:18806102-Mice, Inbred C57BL,
pubmed-meshheading:18806102-Mice, Knockout,
pubmed-meshheading:18806102-Receptors, LDL,
pubmed-meshheading:18806102-Retinoids,
pubmed-meshheading:18806102-beta Carotene
|
pubmed:year |
2008
|
pubmed:articleTitle |
A 9-cis beta-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice.
|
pubmed:affiliation |
The Bert W. Strassburger Lipid Center, Tel-Hashomer; Haifa, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|